Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease

Kidney International, Supplement

Volumn 66, Issue 92, 2004, Pages

  Mann, Johannes F E ^a   Yi, Qi Long ^b   Gerstein, Hertzel C ^b  

^a Klinikum Schwabing   (Germany)

^b NONE

Author keywords

ACE inhibitor; Angiotensin; Cardiovascular; Diabetes; Myocardial infarction; Proteinuria; Ramipril; Stroke

Indexed keywords

ALBUMIN; CREATININE; GLYCOSYLATED HEMOGLOBIN; RAMIPRIL;

ALBUMINURIA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CREATININE URINE LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; HEART DEATH; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERTENSION; KIDNEY DISEASE; MICROALBUMINURIA; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; STROKE; SYSTOLIC BLOOD PRESSURE; ARTERIOSCLEROSIS; DIABETIC NEPHROPATHY; PREDICTION AND FORECASTING; RISK FACTOR;

ALBUMINURIA; ARTERIOSCLEROSIS; DIABETIC NEPHROPATHIES; HUMANS; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 16644372068     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.09215.x     Document Type: Article

References (28)

1. MOGENSEN CE, KEANE WF, BENNETT PH, et al: Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 346:1080-1084, 1995
2. MELTZER S, LEITER L, DANEMAN D. et al: 1998 clinical practice guidelines for the management of diabetes in Canada. Can Med Assoc J 159(Suppl 8):S1-S29, 1998
3. WINGARD DL, BARRETT-CONNOR E: Heart disease and diabetes, in Diabetes in America, edited by Harris MI, Cowie CC, Stern MS, Boyko EJ, Reiber GE, Bennett PH, Washington, National Institutes of Health, 1995, pp 429-448
4. MANN JF, GERSTEIN HC, YI QL, et al: Development of renal disease in people at high cardiovascular risk: Results of the HOPE randomized study. J Am Soc Nephrol 14:641-647, 2003
5. STAMLER J, VACCARO O, NEATON JD, WENTWORTH D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993
6. GOLDBOURT U, YAARI S, MEDALIE JH: Factors predictive of long-term coronary heart disease mortality among 10059 male Israeli civil servants and municipal employees. A 23 year mortality follow-up in the Israeli Ischemic Heart Disease Study. Cardiology 82:100-121, 1993
7. TURNER RC, MILLNS H, NEIL HAW, et al: Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23). BMJ 316:823-828, 1998
8. DINNEEN SF, GERSTEIN HC: The association of microalbuminuria and mortality in non-insulin dependent diabetes mellitus: A systematic overview of the literature. Arch Int Med 157:1413-8, 1997
9. YUDKIN JS, FORREST RD, JACKSON CA: Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington diabetes survey. Lancet 2:530-533, 1988
10. MYKKANEN L, ZACCARO DJ, WAGENKNECHT LE, et al: Microalbuminuria is associated with insulin resistance in nondiabetic subjects: The Insulin Resistance Atherosclerosis Study. Diabetes 47:793-800, 1998
11. CIRILLO M, SENIGALLIESI I, LAURENZI M, et al: Microalbuminuria in nondiabetic adults: Relation of blood pressure, body mass index, plasma cholesterol levels, and smoking. The Gubbio Population Study. Arch Intern Med 158:1933-1939, 1998
12. AGEWALL S, WIKSTRAND J, LJUNGMAN S, FAGERBERG B: Risk Factor Intervention Study Group. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Am J Cardiol 80:164-169, 1997
13. DAMSGAARD EM, FROLAND A, JORGENSEN OD, MOGENSEN CE: Microalbuminuria as predictor of increased mortality in elderly people. BMJ 300:297-300, 1990
14. LJUNGMAN S, WIKSTRAND J, HARTFORD M, BERGLUND G: Urinary albumin excretion - a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. Am J Hypertens 9:770-778, 1998
15. JAGER A, KOSTENSE PJ, HEINE RJ, et al: Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: Five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 19:617-624, 1999
16. BROWN MJ, PALMER CR, CASTAINGE A, et al: Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calcium antagonist or a diuretic in the international nifedipine GITS study: Intervention as a goal in hypertension treatment (INSIGHT). Lancet 356:366-372, 2000
17. THE HOPE INVESTIGATORS: The HOPE (Heart Outcomes and Prevention Evaluation) study: The design of a large, simple randomized trial of an ACE inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. Can J Cardiol 12:127-137, 1996
18. THE HOPE INVESTIGATORS: Effects of an ACE inhibitor, ramipril, on cardiovascular events in high risk patients. New Engl J Med 342:145-153, 2000
19. THE HOPE INVESTIGATORS: Vitamin E supplementation and cardiovascular events in high risk patients. New Engl J Med 342:154-160, 2000
20. THE HOPE INVESTIGATORS: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MicroHOPE substudy. Lancet 355:253-259, 2000
21. GERSTEIN HC, MANN JFE, YI QL, et al: Albuminuria and cardiovascular events, death and heart failure in diabetic and non-diabetic individuals. JAMA 286:421-426, 2001
22. BORCH-JOHNSEN K, FELDT-RASMUSSEN B, STRANDGAARD S, et al: Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 19:1992-1997, 1999
23. KASISKE BL: Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int 31:1153-1159, 1987
24. HALL WD: Abnormalities of kidney function as a cause and a consequence of cardiovascular disease (review). Am J Med Sci 317:176-182, 1999
25. PARFREY PS, FOLEY RN: The clinical epidemiology of cardiac disease in chronic uremia. J Am Soc Nephrol 10:1053-1058, 1999
26. MANN JFE, GERSTEIN HC, POGUE J, et al: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Int Med 134:629-636, 2001
27. JAFAR TH, STARK PC, SCHMID CH, et al: Proteinuia as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int 60:1131-1140, 2001
28. KNUIMAN MW, DIVITINI ML, BUZAS JS, FITZGERALD PEB: Adjustment for regression dilution in epidemiological regression analyses. Ann Epidemiol 8:56-63, 1998